Predicting survival of patients with squamous cell carcinoma

Details Predicting survival of patients with squamous cell carcinoma Predicting survival of patients with squamous cell carcinoma

2005-02-08

2005-02-08

Canella, Karen A. (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S006120, C435S007100, C435S007200, C435S007230, C436S064000

Reexamination Certificate

active

06852483

ABSTRACT:
The invention relates to methods of determining a relative probability of survival for a subject with squamous cell carcinoma by obtaining a biological sample from a subject with squamous cell carcinoma; detecting a level of maspin gene expression in the biological sample; and comparing the level with a threshold level of maspin gene expression. A level of maspin gene expression in the biological sample above the threshold level indicates a relatively high probability of survival, or a level of maspin gene expression in the biological sample below the threshold level indicates a relatively low probability of survival.

REFERENCES:
patent: 5470970 (1995-11-01), Sager et al.
patent: 5801001 (1998-09-01), Sager et al.
patent: 5905023 (1999-05-01), Sager et al.
patent: 5932210 (1999-08-01), Gregory et al.
patent: 6197754 (2001-03-01), Hung et al.
Ding et al, “Differential expression of maspin protein in human adenocarcinomas and squamous cell carcinomas”, Proceeding of the American Association of Cancer Research, 1996, vol. 37, p. 90.*
Petrovich et al (Radiology, 1982, vol. 144, pp. 905-908), abstract.*
Weber et al (Otolaryngology-Head and Neck Surgery, 1988, vol. 99, pp. 16-23), abstract.*
Tytor et al (Clinical Otolaryngology, 1990, vol. 15, pp. 235-252), abstract.*
Eiband et al (American Journal of Surgery, 1989, vol. 158, pp. 314-317), abstract.*
Huwer et al (European Journal of Cardio-Thoracic Surgery, 1992, vol. 6, pp. 498-502), abstract.*
Nagel et al (Zentralblatt fur Chirurgie, 1994, vol. 119, pp. 225-232), abstract.*
van der Velden et al (Cancer, 1995, vol. 75, pp. 2885-2890), abstract.*
abstracts of Ding et al (Proc Amer Assoc Cancer Res, 1996, vol. 37, p. 90).*
Rheinwald et al (Cancer Research, 1981, vol. 41, pp. 1657-1663).*
Pemberton et al, Journal of Histochemistry and Cytochemistry, 1997, vol. 45, pp. 1697-1706.*
Xia et al., “High tumoral maspin . . . ,” Oncogene, 19(20):2398-2403, 2000.
Pemberton et al., “Maspin Is an . . . ,” The Journal of Histochemistry & Cytochemistry, 45(12):1697-1706, 1997.
Sager et al., “Maspin: A Tumor . . . ,” Current Topics in Microbiology 213/I and Immunology, 51-64.
Sheng et al., “Production, Purification . . . ,” The Journal of Biological Chemistry, 269(49):30988-30993, 1994.
Zhang et al., “Transactivation through . . . ,” Cell Growth & Differentiation, 8:179-186, 1997.
Zou et al., “Maspin, a Serpin . . . ,” Science, 263:526-580, 1994.
Zhang et al., “Expression of a . . . ,” Proc. Natl. Acad. Sci. USA, 94:5673-5678, 1997.
Xia et al., “High Tumor Maspin . . . ,” Abstract No. 4381, 91stAnnual Meeting for AAC in San Francisco on Apr. 1-5, 2000, Proceedings of the American Association for Cancer Research, 41:689, 2000.

Affiliated with

Also associated with

Rating

Predicting survival of patients with squamous cell carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Predicting survival of patients with squamous cell carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predicting survival of patients with squamous cell carcinoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3447868